Primer set, kit, method and application for detecting amyl alcohol and MLS_B class drug resistance genes
By designing primer sets targeting amyl alcohols and MLS_B class drug resistance genes and using HNB-LAMP technology, the problem of multi-target detection in existing technologies has been solved, achieving high specificity and low cost in monitoring drug resistance in livestock and poultry, which is suitable for grassroots instant testing and on-site screening.
Patent Information
- Application Number
- CN202611574668.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-10-12
- Publication Date
- 2026-11-10
AI Technical Summary
Existing drug resistance gene detection technologies cannot simultaneously achieve both high amplification efficiency and specificity for multiple targets, making it difficult to meet the needs of large-scale monitoring of drug resistance in livestock and poultry. Furthermore, they suffer from cross-contamination and high costs.
A primer set targeting amyl alcohols and MLS_B class resistance genes was designed. Combined with HNB-LAMP technology, a closed-tube visualization detection method was adopted, using Bst DNA polymerase and hydroxynaphthol blue indicator. The results were determined by visual inspection or colorimeter. The reaction parameters were optimized to achieve high specificity and anti-interference ability.
It achieves highly sensitive detection of ermA, ermB, catA, and floR genes, reduces costs, avoids cross-contamination, is suitable for grassroots point-of-care testing and on-site screening, and improves the repeatability and reliability of test results.
Smart Images

Figure CN123063537A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the fields of molecular biology and in vitro diagnostics, specifically to a primer set, kit, method, and application for detecting amyl alcohol and MLS_B class drug resistance genes. Background Technology
[0002] With the widespread use of antimicrobial drugs in livestock and poultry farming, antibiotic resistance (AMR) has become an increasingly serious problem, severely threatening the development of the livestock industry and global public health security. Pathogenic drug-resistant strains can cause cross-species transmission of resistance genes through horizontal transfer of resistance genes mediated by mobile genetic elements (HGT). Macrolides and amyl alcohols are core veterinary drugs for the prevention and treatment of Gram-positive and Gram-negative bacterial infections, and their corresponding acquired resistance genes are widely prevalent in clinical isolates. Among them, […]. ermA and ermB Encoded ribosomal rRNA methyltransferases can lead to cross-resistance to macrolide drugs in bacteria (cMLS phenotype). catA Gene-encoded chloramphenicol acetyltransferase and floR Genetically encoded specific efflux pumps mediate resistance to amyl alcohol drugs.
[0003] Currently, conventional drug resistance testing technologies have many limitations: traditional bacterial isolation and culture and drug susceptibility testing are time-consuming and difficult to detect unculturable bacteria; ordinary polymerase chain reaction (PCR) relies on expensive variable-temperature thermal cycling equipment, is easily interfered with by biochemical inhibitors in clinical samples, and often needs to be combined with ethidium bromide (EB) gel electrophoresis for interpretation, which cannot meet the needs of point-of-care testing (POCT) at the grassroots level; high-throughput sequencing (NGS) is expensive and data analysis is complex.
[0004] Loop-mediated isothermal amplification (LAMP) technology utilizes Bst DNA polymerase with strand displacement activity to rapidly amplify target nucleic acids at an isothermal temperature of 60℃~65℃, offering advantages such as high specificity and sensitivity. However, the interpretation of conventional LAMP amplification products often relies on turbidimetry (requiring specialized instruments) or chimeric fluorescent dyes such as SYBR Green I (requiring opening the container for addition, which easily leads to aerosol contamination). Hydroxynaphthol blue (HNB), as a built-in colorimetric indicator in the LAMP system, responds to the free magnesium ions (Mg²⁺) generated during amplification due to the precipitation of magnesium pyrophosphate. 2+The concentration of the reagent decreases, causing the reaction solution to change color from purple to blue. This method allows for sealing the tube cap before the reaction, effectively preventing cross-contamination. However, HNB-LAMP is only a general isothermal amplification and colorimetric technology framework, and its detection performance depends entirely on the specificity of the target gene primers and the compatibility of the reaction system. Most existing publicly available LAMP detection products are designed for single pathogens or single drug resistance genes. They cannot simultaneously achieve amplification efficiency and specificity for multiple targets, making it difficult to achieve high-throughput joint detection under unified conditions, thus limiting their application in batch monitoring of drug resistance in livestock and poultry. Summary of the Invention
[0005] To develop a detection product that balances amplification efficiency and specificity for multiple targets, this invention provides a primer set, kit, method, and application for detecting amyloid and MLS_B class resistance genes. The primer set provided by this invention exhibits extremely high target specificity, strong specificity, and excellent anti-interference ability.
[0006] This invention provides a primer set for detecting drug resistance genes, wherein the drug resistance gene is... ermA Gene, ermB Gene, catA Genes and floR Any one or more combinations of genes; The primer set is selected from the detection... ermA Gene, ermB Gene, catA Genes and floR At least one of the primer sets for the gene; Detection ermA The primer set for the gene includes the primers shown in SEQ ID NO.1 to SEQ ID NO.4; Detection ermB The primer set for the gene includes the primers shown in SEQ ID NO.14 to SEQ ID NO.18; Detection catA The primer set for the gene includes the primers shown in SEQ ID NO.38 to SEQ ID NO.42; Detection floR The primer set for the gene includes the primers shown in SEQ ID NO.53 to SEQ ID NO.58.
[0007] The primer set provided by this invention has extremely high target specificity, strong specificity and excellent anti-interference ability.
[0008] The present invention also provides a kit containing the aforementioned primer set.
[0009] Furthermore, the kit also includes an amplification premix containing Bst DNA polymerase, isothermal amplification buffer and a mixture of dNTPs, hydroxynaphthol blue indicator, and positive and negative control substances.
[0010] The magnesium sulfate contained in the premixed mother liquor ensures that the magnesium ion concentration in the final reaction system reaches 7 mmol / L to 8 mmol / L.
[0011] This invention also provides an in vitro visualization detection method for drug resistance genes based on HNB-LAMP, comprising the following steps: Total nucleic acid was extracted from the in vitro sample to be tested as a template; A micro-reaction solution for isothermal amplification is prepared, comprising: pH buffer, Bst DNA polymerase, deoxyribonucleoside triphosphate, magnesium sulfate solution, a specific LAMP primer set, and hydroxynaphthol blue indicator; the specific LAMP primer set is the primer set described in claim 1; the template is added to the micro-reaction solution for isothermal amplification to obtain a reaction mixture; The reaction mixture was incubated at a constant temperature of 61℃~67℃ for 30 minutes to 60 minutes; After the reaction is complete, the color change of the reaction solution is observed with the naked eye, or the color difference value is measured by a colorimeter to determine the result.
[0012] Furthermore, the result of judging the reaction solution by visual observation of the color change is as follows: if the color changes from light purple to light blue, it is judged as positive; if the color remains light purple, it is judged as negative. The color difference value determined by the colorimeter is as follows: The degree of color change of HNB from light purple to light blue is quantitatively evaluated by calculating the total color difference value ΔE between the reaction endpoint and the reaction start point, as well as the shift in the ratio of a* / b*. When ΔE ≥ 5 and the chromaticity coordinate shift ratio a* / b* ≥ -0.10, it is judged as positive; when ΔE ≤ 3.00 and a* / b* ≤ -0.30, it is judged as negative.
[0013] Furthermore, the free Mg in the isothermal amplification micro-reaction solution 2+ The final concentration was 8 mmol / L.
[0014] This invention also provides the application of the primer set or the kit described herein in the preparation of products for detecting resistance genes of macrolide and / or amide alcohol antibiotics.
[0015] Furthermore, the targeted macrolide antibiotic resistance gene includes ermA Genes and ermB Genes; the amide alcohol antibiotic resistance genes include catA Genes and floRGene.
[0016] Compared with the prior art, the beneficial effects of the present invention are as follows: The primer set provided by this invention is used for simultaneous detection of livestock and poultry sources. ermA , ermB , catA , floR Drug resistance genes, for ermA , ermB and floR The limit of detection (LOD) for genes reaches 10. 1 copies / μL, for catA The gene's LOD reaches 10 2 copies / μL.
[0017] The primer set detection method of the present invention also has the following advantages: (1) High specificity and excellent anti-interference ability: The 4-6 specific primers corresponding to each gene work synergistically at a constant temperature of 65℃, ensuring extremely high target specificity and no cross-reaction; Bst polymerase has high natural tolerance to biochemical inhibitors in clinical extracts and is compatible with simple sample pretreatment procedures. (2) Closed tube visualization and prevention of contamination: The HNB chromogenic agent is added in advance to achieve complete closed tube amplification and direct reading of results, completely eliminating the risk of aerosol contamination caused by opening the cap, and completely eliminating the dependence on fluorescence quantitative instruments or electrophoresis equipment. (3) Adaptable to microfluidic chips and reduced cost: The successfully constructed 5μL micro-reaction system not only significantly reduces reagent costs, but also has excellent thermal conductivity, which can be combined with microfluidic chip technology to provide a feasible technical path for point-of-care testing (POCT) and on-site screening of animal epidemiology. (4) Objective interpretation of results and good repeatability: A quantitative color difference interpretation standard matching the color development system of this primer was established, which transforms the subjective judgment of the naked eye into a quantifiable color index, reduces the misjudgment of results caused by differences in personnel operation, and significantly improves the repeatability and reliability of the detection results. Attached Figure Description
[0018] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.
[0019] Figure 1 Target genes ermA Multiple sequence alignment and conserved region analysis diagram.
[0020] Figure 2 Target genes ermB Multiple sequence alignment and conserved region analysis diagram.
[0021] Figure 3 Target genes catA Multiple sequence alignment and conserved region analysis diagram.
[0022] Figure 4 Target genes floR Multiple sequence alignment and conserved region analysis diagram.
[0023] Figure 5 Target genes ermA Different Mg 2+ The effect of concentration on the endpoint ΔE value and the a* / b* value is shown in the graph.
[0024] Figure 6 Target genes ermB Different Mg 2+ The effect of concentration on the endpoint ΔE value and the a* / b* value is shown in the graph.
[0025] Figure 7 Target genes catA Different Mg 2+ The effect of concentration on the endpoint ΔE value and the a* / b* value is shown in the graph.
[0026] Figure 8 Target genes floR Different Mg 2+ The effect of concentration on the endpoint ΔE value and the a* / b* value is shown in the graph.
[0027] Figure 9 To study the effects of different reaction temperatures (61–67 °C) on target genes ermA A comparison chart showing the effect of the system's endpoint color development.
[0028] Figure 10 To study the effects of different reaction temperatures (61–67 °C) on target genes ermB A comparison chart showing the effect of the system's endpoint color development.
[0029] Figure 11 To study the effects of different reaction temperatures (61–67 °C) on target genes catA A comparison chart showing the effect of the system's endpoint color development.
[0030] Figure 12 To study the effects of different reaction temperatures (61–67 °C) on target genes floR A comparison chart showing the effect of the system's endpoint color development.
[0031] Figure 13 Target genes ermA Chromogenic kinetics (4PL regression) curve of reaction time gradient.
[0032] Figure 14 Target genes ermB Chromogenic kinetics (4PL regression) curve of reaction time gradient.
[0033] Figure 15 Target genes catA Chromogenic kinetics (4PL regression) curve of reaction time gradient.
[0034] Figure 16 Target genes floR Chromogenic kinetics (4PL regression) curve of reaction time gradient.
[0035] Figure 17 Target genes ermA The results of the HNB-LAMP detection sensitivity (LOD) test are shown in the figure. In the diagram, A represents the initial 10 reactions. 7 -10 4 copies / μL ermA Genes; where numbers 1 to 8 are respectively: 1 to 2: 10 7 copies / μL; 3–4:10 6 copies / μL; 5–6:10 5 copies / μL; 7–8:10 4 copies / μL; B represents the first 10 reactions. 3 ~10 0 copies / μL ermA Genes; among them, numbers 9 to 16 are respectively: 9 to 10: 10 3 copies / μL; 11–12: 10 2 copies / μL; 13–14: 10 1 copies / μL; 15–16: 10 0 copies / μL; C represents the reaction time after 10... 7 ~10 4 copies / μL ermA Genes; where numbers 1 to 8 are respectively: 1 to 2: 10 7 copies / μL; 3–4:10 6 copies / μL; 5–6:10 5 copies / μL; 7–8:10 4 copies / μL; D represents 10 after the reaction. 3 ~10 0copies / μL ermA Genes; among them, numbers 9 to 16 are respectively: 9 to 10: 10 3 copies / μL; 11–12: 10 2 copies / μL; 13–14: 10 1 copies / μL; 15–16: 10 0 copies / μL.
[0036] Figure 18 Target genes ermB The results of the HNB-LAMP detection sensitivity (LOD) test are shown in the figure. In the diagram, A represents the initial 10 reactions. 7 ~10 4 copies / μL ermB Genes; where numbers 1 to 8 are respectively: 1 to 2: 10 7 copies / μL; 3–4:10 6 copies / μL; 5–6:10 5 copies / μL; 7–8:10 4 copies / μL; B represents the first 10 reactions. 3 ~10 0 copies / μL ermB Genes; among them, numbers 9 to 16 are respectively: 9 to 10: 10 3 copies / μL; 11–12: 10 2 copies / μL; 13–14: 10 1 copies / μL; 15–16: 10 0 copies / μL; C represents the reaction time after 10... 7 ~10 4 copies / μL ermB Genes; where numbers 1 to 8 are respectively: 1 to 2: 10 7 copies / μL; 3–4:10 6 copies / μL; 5–6:10 5 copies / μL; 7–8:10 4 copies / μL; D represents 10 after the reaction. 3 ~10 0 copies / μL ermB Genes; among them, numbers 9 to 16 are respectively: 9 to 10: 10 3copies / μL; 11–12: 10 2 copies / μL; 13–14: 10 1 copies / μL; 15–16: 10 0 copies / μL.
[0037] Figure 19 Target genes catA The results of the HNB-LAMP detection sensitivity (LOD) test are shown in the figure. In the diagram, A represents the initial 10 reactions. 7 ~10 4 copies / μL catA Genes; where numbers 1 to 8 are respectively: 1 to 2: 10 7 copies / μL; 3–4:10 6 copies / μL; 5–6:10 5 copies / μL; 7–8:10 4 copies / μL; B represents the first 10 reactions. 3 ~10 0 copies / μL catA Genes; among them, numbers 9 to 16 are respectively: 9 to 10: 10 3 copies / μL; 11–12: 10 2 copies / μL; 13–14: 10 1 copies / μL; 15–16: 10 0 copies / μL; C represents the reaction time after 10... 7 ~10 4 copies / μL catA Genes; where numbers 1 to 8 represent 1 to 2:10 respectively. 7 copies / μL; 3–4:10 6 copies / μL; 5–6:10 5 copies / μL; 7–8:10 4 copies / μL; D represents 10 after the reaction. 3 ~10 0 copies / μL catA Genes; among them, numbers 9 to 16 are respectively: 9 to 10: 10 3 copies / μL; 11–12: 10 2 copies / μL; 13–14: 10 1copies / μL; 15–16: 10 0 copies / μL.
[0038] Figure 20 Target genes floR The results of the HNB-LAMP detection sensitivity (LOD) test are shown in the figure. In the diagram, A represents the initial 10 reactions. 7 ~10 4 copies / μL floR Genes; where numbers 1 to 8 are respectively: 1 to 2: 10 7 copies / μL; 3–4:10 6 copies / μL; 5–6:10 5 copies / μL; 7–8:10 4 copies / μL; B represents the first 10 reactions. 3 ~10 0 copies / μL floR Genes; among them, numbers 9 to 16 are respectively: 9 to 10: 10 3 copies / μL; 11–12: 10 2 copies / μL; 13–14: 10 1 copies / μL; 15–16: 10 0 copies / μL; C represents the reaction time after 10... 7 ~10 4 copies / μL floR Genes; where numbers 1 to 8 are respectively: 1 to 2: 10 7 copies / μL; 3–4:10 6 copies / μL; 5–6:10 5 copies / μL; 7–8:10 4 copies / μL; D represents 10 after the reaction. 3 ~10 0 copies / μL floR Genes; among them, numbers 9 to 16 are respectively: 9 to 10: 10 3 copies / μL; 11–12: 10 2 copies / μL; 13–14: 10 1 copies / μL; 15–16: 10 0 copies / μL.
[0039] Figure 21 for ermA Comparison of endpoint ΔE values and a* / b* values for different gene testing subjects.
[0040] Figure 22 for ermB Comparison of endpoint ΔE values and a* / b* values for different gene testing subjects.
[0041] Figure 23 for catA Comparison of endpoint ΔE values and a* / b* values for different gene testing subjects.
[0042] Figure 24 for floR Comparison of endpoint ΔE values and a* / b* values for different gene testing subjects.
[0043] Figure 25 for ermA A comparison of gene amplification and visualization in a 5μL microfluidic tube system; in the figure, A represents the amplification before the reaction. ermA Positive and negative controls; where numbers 1 to 4 are respectively: 1 to 2: containing ermA Positive samples; 3-4: negative controls (sterile, enzyme-free water); B is the result after the reaction. ermA Positive and negative controls; where numbers 1 to 4 are respectively: 1 to 2: containing ermA 3-4: Positive samples; 4-5: Negative controls (sterile, enzyme-free water).
[0044] Figure 26 for ermB A comparison of gene amplification and visualization in a 5μL microfluidic tube system; in the figure, A represents the amplification before the reaction. ermB Positive and negative controls; where numbers 1 to 4 are respectively: 1 to 2: containing ermA Positive samples; 3-4: negative controls (sterile, enzyme-free water); B is the result after the reaction. ermB Positive and negative controls; where numbers 1 to 4 are respectively: 1 to 2: containing ermA 3-4: Positive samples; 4-5: Negative controls (sterile, enzyme-free water).
[0045] Figure 27 for catA A comparison of amplification and visualization of a 5μL microfluidic-compatible tube system; in the figure, A represents the amplification process before the reaction. catA Positive and negative controls; where numbers 1 to 4 represent 1 to 2 respectively: containing ermA Positive samples; 3-4: negative controls (sterile, enzyme-free water); B is the result after the reaction. catA Positive and negative controls; where numbers 1 to 4 represent 1 to 2 respectively: containing ermA3-4: Positive samples; 4-5: Negative controls (sterile, enzyme-free water).
[0046] Figure 28 for floR A comparison of amplification and visualization of a 5μL microfluidic-compatible tube system; in the figure, A represents the amplification process before the reaction. floR Positive and negative controls; where numbers 1 to 4 are respectively: 1 to 2: containing floR Positive samples; 3-4: negative controls (sterile, enzyme-free water); B is the result after the reaction. floR Positive and negative controls; where numbers 1 to 4 are respectively: 1 to 2: containing ermA 3-4: Positive samples; 4-5: Negative controls (sterile, enzyme-free water).
[0047] Figure 29 for ermA Gel electrophoresis image after gene PCR amplification; in the image, 1-45 are different random bacterial DNA samples; + represents positive control (containing...). ermA DNA sample of the gene); - is a negative control (containing no DNA sample of the gene). ermA DNA sample of the gene; blank is the blank control (sterile, enzyme-free water).
[0048] Figure 30 for ermA HNB-LAMP colorimetric reaction diagram; in the diagram, 1-45 represent different random bacterial DNA samples; + indicates a positive control (containing...). ermA DNA sample of the gene); - is a negative control (containing no DNA sample of the gene). ermA DNA sample of the gene; blank is the blank control (sterile, enzyme-free water).
[0049] Figure 31 for ermB Gel electrophoresis image after gene PCR amplification; in the image, 1-45 are different random bacterial DNA samples; + represents positive control (containing...). ermB DNA sample of the gene); - is a negative control (containing no DNA sample of the gene). ermB DNA sample of the gene; blank is the blank control (sterile, enzyme-free water).
[0050] Figure 32 for ermB HNB-LAMP colorimetric reaction diagram; in the diagram, 1-45 represent different random bacterial DNA samples; + indicates a positive control (containing...). ermB DNA sample of the gene); - is a negative control (containing no DNA sample of the gene). ermB DNA sample of the gene; blank is the blank control (sterile, enzyme-free water).
[0051] Figure 33 for catAGel electrophoresis image after gene PCR amplification; in the image, 1-45 are different random bacterial DNA samples; + represents positive control (containing...). catA DNA sample of the gene); - is a negative control (containing no DNA sample of the gene). catA DNA sample of the gene; blank is the blank control (sterile, enzyme-free water).
[0052] Figure 34 for catA HNB-LAMP colorimetric reaction diagram; in the diagram, 1-45 represent different random bacterial DNA samples; + indicates a positive control (containing...). catA DNA sample of the gene); - is a negative control (containing no DNA sample of the gene). catA DNA sample of the gene; blank is the blank control (sterile, enzyme-free water).
[0053] Figure 35 for floR Gel electrophoresis image after gene PCR amplification; In the figure, 1-45 represent different random bacterial DNA samples; + indicates a positive control (containing...). floR DNA sample of the gene); - is a negative control (containing no DNA sample of the gene). floR DNA sample of the gene; blank is the blank control (sterile, enzyme-free water).
[0054] Figure 36 for floR HNB-LAMP colorimetric reaction diagram; in the diagram, 1-45 represent different random bacterial DNA samples; + indicates a positive control (containing...). floR DNA sample of the gene); - is a negative control (containing no DNA sample of the gene). floR DNA sample of the gene; blank is the blank control (sterile, enzyme-free water). Detailed Implementation
[0055] The specific embodiments of the present invention are described in detail below, but it should be understood that the scope of protection of the present invention is not limited to the specific embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention. Unless otherwise specified, the experimental methods described in the embodiments of the present invention are conventional methods, and the materials and reagents used in the following embodiments are commercially available unless otherwise specified.
[0056] Example 1: A method for simultaneous detection ermA , ermB , catA , floR Primers, kits, and applications of genes.
[0057] I. Experimental Methods 1. Target sequence conserved region analysis and LAMP primer set design and screening Sequence collection and conservative region screening: Retrieve and download sequences from the NCBI database. ermA , ermB , catA , floR Forty reference sequences from common pathogenic bacteria were selected from each of the past five years. Multiple sequence alignment was performed using MegAlign software, and conserved regions with greater than 99% homology were selected as target sequences. ermA Select the CDS with NCBI accession number M11180.1; ermB Select the CDS with NCBI accession number X52980.1; catA Select the CDS with NCBI accession number V00622.1; floR Select the CDS with NCBI accession number AF111629.1 to ensure broad primer coverage and avoid missed detections due to strain sequence variations.
[0058] Primer design and screening: Three sets of candidate LAMP primers were designed for each target gene using online software. The melting temperature (Tm) and secondary structure of the primers were optimized and evaluated (Tm of 64℃~66℃ for the Fc / Bc region, and Tm of 59℃~61℃ for the F2 / B2 and F3 / B3 regions). The nucleotide sequence with the shortest amplification peak time and a single specific melting peak was selected as the optimal primer set using the SYBR Green I quantitative fluorescence platform.
[0059] The targeted drug resistance gene obtained in this invention ( ermA , ermB , catA , floR The specific sequences of the LAMP-specific primer set (outer primers: F3, B3; inner primers: FIP, BIP; loop primers: LF, LB) are as follows: (1) Targeting ermA Three sets of candidate primers for the gene: The first group is: F3-1:ATTGCAAAATCTGCAACGA (SEQ ID NO.1); B3-1:CGATACTTTTTGTAGTCCCTTCT (SEQ ID NO.2); FIP-1:AGTGGTGGTACTTTTTTGAGCAGCTTTGGGTTTACTATTAATGGTG (SEQ ID NO.3); BIP-1:TTCATCCTAAGCCAAGTGTAGACTGAAATCAATGGTTGATGTCGTT (SEQ ID NO. 4).
[0060] The second group is: F3-2:TCCCTTATAACATCAGTACGGATA (SEQ ID NO.5); B3-2:CAGAGTCTACACTTGGCTTA (SEQ ID NO.6); FIP-2:CGCAAATCCCTTCTCAACGATAAGGTCAAAAGAATTACCTTTGAAAGTC (SEQ ID NO.7); BIP-2:TGCAACGAGCTTTGGGTTTACTGGATGAAAATATAGTGGTGGTAC (SEQ ID NO. 8); The third group is: F3-3:GAAAGTCAGGCTAAATATAGCT (SEQ ID NO.9); B3-3:GATCGATACTTTTTGTAGTCCCTT (SEQ ID NO.10); FIP-3:AGCATTTTTATATCCATCTCCACCATTGAGAAGGGATTTGCGA (SEQ ID NO. 11); BIP-3:TTCATCCTAAGCCAAGTGTAGACTGAAATCAATGGTTGATGTCGTT (SEQ ID NO. 12); LF-3:GCTCCGTTGCAGATTTTGCAATCT (SEQ ID NO. 13).
[0061] (2) Regarding ermB Primer set of the gene: The first group is: F3-1:ATCTGATTGTTGAAGAAGGATT (SEQ ID NO.14); B3-1:CTTCCAATATTTATCTGGAACATC (SEQ ID NO.15); FIP-1:TAAGCAATTGCTGAATCGAGACTTGTACCTTGGATATTCACCGAA (SEQ ID NO. 16); BIP-1:TGCCAGCGGAATGCTTTCATTGTGGTATGGCGGTAAG (SEQ ID NO. 17); LF-1:TGTGCAAGAGCAACCTAGTG (SEQ ID NO. 18); The second group is: F3-2:ATCTGATTGTTGAAGAAGGATT (SEQ ID NO.19); B3-2:CTTCCAATATTTATCTGGAACATC (SEQ ID NO.20); FIP-2:TAAGCAATTGCTGAATCGAGACTTGTACCTTGGATATTCACCGAA (SEQ ID NO. 21); BIP-2:TGCCAGCGGAATGCTTTCATTGTGGTATGGCGGTAAG (SEQ ID NO. 22); LF-2:TGTGCAAGAGCAACCTAGTG (SEQ ID NO. 23); The third group is: F3-3:CTACAAGCGTACCTTGGAT (SEQ ID NO. 24); B3-3:ACAAAGTACGTATATAGCTTCCA (SEQ ID NO.25); FIP-3:CAGCTTAAGCAATTGCTGAATCGATTCACCGAACACTAGGGT (SEQ ID NO. 26); BIP-3: CCAGCGGAATGCTTTCATCCTGTGGTATGGCGGGTAAG (SEQ ID NO. 27).
[0062] (3) Targeting catA Primer set of the gene: The first group is: F3-1: ATCACTACCGGGCGTATT (SEQ ID NO.28); B3-1: TTAAAAGGCCGTAATATCCAG (SEQ ID NO. 29); FIP-1:CAACGGTGGTATCCAGTGATTTTTTGAGTTATCGAGATTTTCAGGA (SEQ ID NO. 30); BIP-1:TCCCAATGGCATCGTAAAGAACAACGGTCTGGTTATAGGTACA (SEQ ID NO. 31); LB-1:GAGGCATTTCAGTCAGTTGCTCA (SEQ ID NO. 32); The second group is: F3-2:ATCCCAATGGCATCGTAA (SEQ ID NO.33); B3-2: CCATATCACCAGCTCACC (SEQ ID NO.34); FIP-2:TCCAGCTGAACGGTCTGGTTAAACATTTTGAGGCATTTCAGTC (SEQ ID NO. 35); BIP-2:ATAAGCACAAGTTTTATCCGGCCATTCCGGATGAGCATTCA (SEQ ID NO. 36); LB-2: TTTATTCACATTCTTGCCCGCCT (SEQ ID NO. 37); The third group is: F3-3:CCGTAAAGAAAAATAAGCACAAG (SEQ ID NO.38); B3-3:TTCACTCCAGAGCGATGA (SEQ ID NO.39); FIP-3:ACGGAATTCCGGATGAGCATTTTTATCCGGCCTTTATTCACA (SEQ ID NO. 40); BIP-3:TGGCAATGAAAGACGGTGAGCGTTTCAGTTTGCTCATGG (SEQ ID NO. 41); LB-3:GGTGATATGGGATAGTGTTCACCCT (SEQ ID NO. 42).
[0063] (4) Targeting floR Primer set of the gene: The first group is: F3-1:GTGCTcatAGGCCAAGCG (SEQ ID NO.43); B3-1: GAGCCGTAAAGTTCGCCG (SEQ ID NO.44); FIP-1: GCGAAACGGGTTGTCACGATCAATTCCGAGATCGGATTCAGC (SEQ ID NO.45); BIP-1: AAGTCCTTTGTCGCCAGATGGGGCTCCGCAAACAAGCAAC (SEQ ID NO.46); LB-1: ATCGCAGGATGCGTGGC (SEQ ID NO.47); The second group is: F3-2: TGGCTATACTGGCGATGCT (SEQ ID NO.48); B3-2: CGCTTGGCCTATGAGCAC (SEQ ID NO.49); FIP-2: CAGATCGGCGCGTCTTGACTTGTCCTAAATGCGGGTTTCAGG (SEQ ID NO.50); BIP-2: TCTTGCCGATCTTCGCGAGTCAAGACGAAGTAGGTGCCCAT (SEQ ID NO.51); LB-2: TGGGTTTACACTGTCGGCTTTAG (SEQ ID NO.52); The third group is: F3-3: GATCGGATTCAGCTTTGCCT (SEQ ID NO.53); B3-3: CGGTAGGATGAAGGTGAGGA (SEQ ID NO.54); FIP-3: GCCCCATCTGGCGACAAAGGGTCGCGCTTGTAATGATCGT (SEQ ID NO.55); BIP-3: CGTGGGATGGCGTTGCTTGTCGGCGAGCCGTAAAGTTC (SEQ ID NO.56); LF-3: ACTTCGCGAAACGGGTTGT (SEQ ID NO.57); LB-3: TTGCGGAGCGGTCCTGT (SEQ ID NO.58).
[0064] By targeting drug resistance genes ( ermA , ermB , catA , floRThe T initiation value and CV stability coefficient of the specific LAMP primer set were screened, and the results are as follows: Table 1 Targeting drug resistance genes ermA Comparison results of specific LAMP primer sets As shown in Table 1, ermA The first set of primers (SEQ ID NO.1~SEQ ID NO.4) was selected for gene amplification, which started at an average of 18 minutes and had the lowest CV value of 1.48%.
[0065] Table 2 Targeting drug resistance genes ermB Comparison results of specific LAMP primer sets As shown in Table 2 ermB The first set of primers (SEQ ID NO.14~SEQ ID NO.18) was selected for gene amplification, which started at an average of 10 minutes and had the lowest CV value of 0.59%; the third set of primers did not amplify and was not selected.
[0066] Table 3 Targeting drug resistance genes catA Comparison results of specific LAMP primer sets As shown in Table 3 catA The third set of primers (SEQ ID NO.38~SEQ ID NO.42) were selected for gene amplification, which started at an average of 21 minutes and had the lowest CV value of 0.69%.
[0067] Table 4 Targeting drug resistance genes floR Comparison results of specific LAMP primer sets As shown in Table 4 floR The third set of primers (SEQ ID NO.53~SEQ ID NO.58) was selected for gene amplification, which started at an average of 33 minutes and had the lowest CV value of 1.29%. The CV value of the second set of primers was too high.
[0068] The optimal primer set obtained through the above screening was further tested in the following experiments.
[0069] 2. Preparation of the standard HNB-LAMP reaction system Add the components listed in Table 5 to sterile microcentrifuge tubes.
[0070] Table 5 Standard HNB-LAMP reaction system reagent components Added amount Bst Ⅱ Pro DNA Polymerase Large Fragment 0.5μL 10×IsothermAlAmp Buffer 1.25μL <![CDATA[MgSO4 solution (100 mmol / L)]]> 0.75μL dNTPs Mix (10 mmol / L each) 1.75μL HNB colorimetric dye (10×) 1.75μL Internal primer (40 μmol / L) 0.5μL External primer (5 μmol / L) 0.5μL Loop primer (10 μmol / L) 0.5μL Template DNA 2μL <![CDATA[ddH2O]]> Bring the volume to 12.5 μL. 3. Optimization of key parameters of the reaction system Prepare the LAMP reaction system according to the components in Table 1: The system contains 10× Isotherm AlAmp Buffer, Bst DNA Polymerase (Bst II Pro DNA Polymerase Large Frame), dNTPs Mix, magnesium sulfate (MgSO4) solution, specific primer set (inner primer, outer primer, and loop primer), HNB indicator (HNB chromogenic dye), template DNA (contains the target gene as confirmed by PCR), and bring the volume to the predetermined volume of 12.5 μL with ddH2O.
[0071] Incubate the reaction system at a constant temperature of 61℃~67℃ for 30~40 minutes. After the reaction, observe the color change of the reaction solution with the naked eye, or determine the result by measuring the color difference value with a colorimeter. Qualitative determination is made by observing the color change of the liquid in the closed reaction tube with the naked eye: if the color changes from light purple to light blue, it is judged as positive; if the color remains light purple, it is judged as negative.
[0072] To achieve objective quantification, the degree of HNB color change from light purple (negative) to light blue (positive) is quantitatively evaluated by calculating the total color difference ΔE between the reaction endpoint and the reaction initiation point, as well as the shift in the ratio of a* / b*. A positive result is defined as ΔE ≥ 5 and the chromaticity coordinate shift ratio a* / b* ≥ -0.10; a negative result is defined as ΔE ≤ 3.00 and a* / b* ≤ -0.30. To ensure amplification efficiency and colorimetric specificity, this invention controls the key parameters of the reaction system (Mg... 2+ The concentration, reaction temperature, and reaction time were optimized.
[0073] The single-factor variable method was used to optimize and verify the parameters of the reaction system.
[0074] (1) Mg 2+ Concentration optimization: By setting different concentrations of MgSO4 solution in the system shown in Table 1, the concentration of Mg in the reaction system was controlled. 2+ Concentrations of 4 mmol / L, 6 mmol / L, 8 mmol / L, and 10 mmol / L were used. Different Mg... 2+ The reaction systems of different concentrations were incubated at 65°C for 40 minutes. After the reaction, the color difference was measured using a colorimeter to determine the results.
[0075] The results are as follows Figures 5-8 As shown, when the concentration is 4 mmol / L to 6 mmol / L, the polymerization extension kinetics are insufficient and the color change is weak; at a concentration of 10 mmol / L, a large amount of residual Mg... 2+This hindered the conformational transition of HNB, resulting in false negatives; the system's amplification and colorimetric efficiency reached its peak at a final concentration of 8 mmol / L. This indicates that free Mg in the reaction system... 2+ The optimal final concentration is 8 mmol / L.
[0076] (2) Optimization of reaction temperature: Set the temperature gradient to 61℃, 63℃, 65℃ and 67℃.
[0077] According to the optimal system (i.e., 8 mmol / L Mg) 2+ Prepare the reaction system and incubate it at 61℃, 63℃, 65℃, and 67℃ for 60 minutes each. After the reaction is complete, measure the color difference value using a colorimeter to determine the result.
[0078] The results are as follows Figures 9-12 As shown, one-way ANOVA confirmed that the amplification time of each target gene was the shortest and the specificity was the highest under the condition of 65℃.
[0079] (3) Optimization of reaction time: The reaction time gradients are set as follows: 15, 20, 25, 30, 35, 40, 45, 50, 55 and 60 minutes.
[0080] The reaction system was prepared according to Table 1 and incubated at 65°C for different times (15, 20, 25, 30, 35, 40, 45, 50, 55, and 60 minutes). After the reaction was completed, the color difference value was measured using a colorimeter to determine the result.
[0081] The results are as follows Figures 13-16 As shown, a significant color transition occurred in the system between 30 and 35 minutes. To balance detection efficiency and prevent non-specific amplification of primer dimers caused by excessive time, the optimal reaction window was determined to be 35 to 60 minutes.
[0082] 4. Determination of analytical sensitivity (LOD) Prepare the reaction system according to Table 1. Dilute the Salmonella genomic DNA containing the target gene serially with sterile, enzyme-free water in a 10-fold gradient (10). 7 ~10 0 The reaction system was incubated at 65°C for 40 minutes. Color changes were observed visually after the reaction. Salmonella genomic DNA was extracted using the bacterial genomic DNA extraction kit (centrifuge column type) with catalog number (REF) DP302-02 provided by TIANGEN (Tiangen Biotech (Beijing) Co., Ltd.).
[0083] The results are as follows Figures 17-20 As shown, for ermA , ermB , floR Genes, system at template concentration of 101 It can still stably exhibit a color change from purple to blue even at copies / μL; targeting catA Genes, with a detection limit of 10. 2 The results show that the method of the present invention has excellent detection capability for low-abundance samples.
[0084] 5. Specificity evaluation HNB-LAMP assays were performed using Salmonella genomic DNA containing the target gene, Salmonella genomic DNA containing other non-targeted drug resistance genes, and blank deionized water as templates. The reaction systems were incubated at 65°C for 40 minutes. After the reaction, the color difference was measured using a colorimeter to determine the results. Both Salmonella genomic DNA and Salmonella genomic DNA containing other non-targeted drug resistance genes were extracted using the bacterial genomic DNA extraction kit (centrifuge column type) with catalog number (REF) DP302-02 provided by TIANGEN (Tiangen Biotech (Beijing) Co., Ltd.). After PCR detection, the DNA containing… ermA Gene, ermB Gene, floR Genes and catA The bacterial genomic DNA containing the target gene is denoted as Salmonella genomic DNA containing the target gene, and does not contain it after PCR detection. ermA Gene, ermB Gene, floR Genes and catA The bacterial genomic DNA of the gene is denoted as Salmonella genomic DNA of other non-targeted drug resistance genes. Blank sterile, enzyme-free water serves as a negative control.
[0085] The results are as follows Figures 21-24 The reaction system exhibited a significant chromogenic mutation (light blue) only upon the addition of the corresponding target gene template; all cross-interference groups maintained their ground-state purple color, and the color difference measurement results showed no significant difference from the blank control. This indicates that the specific primer set designed in this invention has excellent detection specificity and is free from cross-variation interference.
[0086] 6. Validation of the 5 μL ultra-micro reaction system According to the component ratios in Table 1, the overall reaction volume was reduced proportionally to prepare a 5 μL system. This system was then incubated in a 65°C heating device for 40 minutes. After the reaction was complete, the color change of the reaction solution was observed visually.
[0087] The results are as follows Figures 25-28The micro-upgraded system, due to its higher surface area to volume ratio, exhibits amplification peak efficiency that is no inferior to the conventional 12.5 μL system, with significant color difference at the endpoint and easily identifiable color change. This embodiment demonstrates the feasibility of integrating this reaction system onto a microfluidic chip based on PDMS or PC matrix, which can further save reagent costs and achieve fully enclosed automated detection.
[0088] 7. Comparison with real clinical samples Forty-five fecal samples were collected from pigs exhibiting clinical symptoms of diarrhea. Nucleic acid was extracted and used as a detection template. Parallel conventional PCR validation and comparative analysis were performed with the HNB-LAMP detection method provided in this invention. The PCR reaction system is shown in Table 6.
[0089] Table 6 PCR Reaction System Components Volume (25 μL system) 2×Taq PCR MasterMix 12.5 μL Upstream primer F (10 μM) 1.0 μL (final concentration 0.4 μM) Downstream primer R (10 μM) 1.0 μL (final concentration 0.4 μM) Template DNA 2.0 μL <![CDATA[Sterile ddH₂O]]> Make up to 25 μL The PCR amplification procedures are as follows: ermA , ermB Gene: 94 ℃ pre-denaturation for 5 min; 35 cycles: 94 ℃ denaturation for 30 s, 52 ℃ annealing for 40 s, 72 ℃ extension for 1 min; 72 ℃ final extension for 10 min; store at 4 ℃.
[0090] floR , catA Gene: 94 ℃ pre-denaturation for 5 min; 35 cycles: 94 ℃ denaturation for 30 s, 54 ℃ annealing for 40 s, 72 ℃ extension for 1 min; 72 ℃ final extension for 10 min; store at 4 ℃.
[0091] The HNB-LAMP detection method provided by this invention involves preparing the reaction system according to Table 5, and incubating at 65°C for 40 minutes under the following conditions: color difference value is measured using a colorimeter to determine the result.
[0092] The results show that the determination results of this invention are highly consistent with those of the "gold standard" PCR method: Through sorting Figures 29-30 The data is presented in Table 7, and the statistics are as follows. ermA The concordance rates for positive and negative genes were 93.8% and 100%, respectively.
[0093] Table 7 ermA Statistics on the concordance rate of gene positive and negative results Sample number 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 PCR - + - + - - - + - - - - + + - HNB-LAMP - - - + - - - + - - - - + + - Sample number 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 PCR - - - + + - - - - - - - + + + HNB-LAMP - - - + + - - - - - - - + + + Sample number 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 PCR + - + - + - - - + + + - - - - HNB-LAMP + - + - + - - - + + + - - - - Through sorting Figures 31-32 The data is presented in Table 8, and the statistics are as follows. ermB The concordance rates for positive and negative genes were 100% and 94.7%, respectively.
[0094] Table 8 ermB Statistics on the concordance rate of gene positive and negative results Sample number 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 PCR + + - - - - - + + - - + - + - HNB-LAMP + + - + - - - + + - - + - + - Sample number 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 PCR + + + - - - - + - - - + + - + HNB-LAMP + + + - - - - + - - - + + - + Sample number 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 PCR + + + + + + + + + + + + - + - HNB-LAMP + + + + + + + + + + + + - + - Through sorting Figures 33-34 The data is presented in Table 9, and the statistics are as follows. catA The concordance rates for positive and negative gene results were 94.0% and 91.7%, respectively.
[0095] Table 9 catA Statistics on the concordance rate of gene positive and negative results Sample number 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 PCR + + + + - + + + + - - - + + + HNB-LAMP + + + + - + + + + - - - + + + Sample number 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 PCR + - + + + + + + + - - + + + + HNB-LAMP + - + + + + - - + - - + + + + Sample number 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 PCR + + + + + - - - + + + - + + - HNB-LAMP + + + + + - - - + + + - + + - Through sorting Figures 35-36 The data is presented in Table 10, and the statistics are as follows. floR The concordance rates for positive and negative genes were 100% and 94.1%, respectively.
[0096] Table 10 floR Statistics on the concordance rate of gene positive and negative results Sample number 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 PCR + + + + - - + + + + - - + + - HNB-LAMP + + + + - - + + + + - - + + - Sample number 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 PCR + + + + - - - + + - + + + + - HNB-LAMP + + + + - - - + + - + + + + - Sample number 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 PCR - + + + - - + + + - + - - + - HNB-LAMP + + + + - - + + + - + - - + - A few differences mainly stem from the higher sensitivity of LAMP technology (to detect low-copy latent strains) or its extremely strict specificity requirements (to filter wild-type point mutants).
[0097] 8. Establishment of color difference quantification and interpretation standards The HNB system judges reaction results by observing color changes. This invention, based on conventional visual observation, introduces a digital colorimetric evaluation method. Images are captured using a smartphone, and their colors are mapped to the CIE L*a*b* standard color space. The degree of color change of HNB from light purple (negative) to light blue (positive) is quantitatively evaluated by calculating the total color difference ΔE between the reaction endpoint and the reaction initiation point, as well as the shift in the a* / b* ratio (see Table 11). Each color corresponds to a standard a* / b* value range, and the evaluation criteria are shown below. This method aims to eliminate subjective errors from manual interpretation, precisely locking the optimal amplification efficiency in primer screening through numerical thresholding, ensuring the reproducibility and objectivity of experimental results.
[0098] Table 11 Color Difference Quantification Interpretation Standards Color (qualitative) △E range Range of a* / b* values Light purple (negative) ≤3.00 ≤-0.30 blue-purple 3.00 ~ 5.00 -0.30 ~ -0.10 Light blue (positive) ≥5.00 ≥-0.10 Although preferred embodiments of the invention have been described, those skilled in the art, upon learning the basic inventive concept, can make other changes and modifications to these embodiments.
[0099] Obviously, those skilled in the art can make various modifications and variations to this invention without departing from its spirit and scope. Therefore, if these modifications and variations fall within the scope of the claims of this invention and their equivalents, this invention also intends to include these modifications and variations.
Claims
1. A primer set for detecting drug resistance genes, characterized in that, The drug resistance gene is ermA Gene, ermB Gene, catA Genes and floR Any one or more combinations of genes; The primer set is selected from the detection... ermA Gene, ermB Gene, catA Genes and floR At least one of the primer sets for the gene; Detection ermA The primer set for the gene includes the primers shown in SEQ ID NO.1 to SEQ ID NO.4; Detection ermB The primer set for the gene includes the primers shown in SEQ ID NO.14 to SEQ ID NO.18; Detection catA The primer set for the gene includes the primers shown in SEQ ID NO.38 to SEQ ID NO.42; Detection floR The primer set for the gene includes the primers shown in SEQ ID NO.53 to SEQ ID NO.
58.
2. A kit containing the primer set of claim 1.
3. The reagent kit according to claim 2, characterized in that, The kit also includes an amplification premix containing Bst DNA polymerase, isothermal amplification buffer and a mixture of dNTPs, hydroxynaphthol blue indicator, and positive and negative control substances.
4. The reagent kit according to claim 3, characterized in that, The magnesium sulfate contained in the premixed mother liquor ensures that the magnesium ion concentration in the final reaction system reaches 7 mmol / L to 8 mmol / L.
5. An in vitro visualization detection method for drug resistance genes based on HNB-LAMP, characterized in that, Includes the following steps: Total nucleic acid was extracted from the in vitro sample to be tested as a template; A micro-reaction solution for isothermal amplification is prepared, comprising: pH buffer, Bst DNA polymerase, deoxyribonucleoside triphosphate, magnesium sulfate solution, a specific LAMP primer set, and hydroxynaphthol blue indicator; the specific LAMP primer set is the primer set described in claim 1; the template is added to the micro-reaction solution for isothermal amplification to obtain a reaction mixture; The reaction mixture was incubated at a constant temperature of 61℃~67℃ for 30 minutes~60 minutes; After the reaction is complete, the color change of the reaction solution is observed with the naked eye, or the color difference value is measured by a colorimeter to determine the result.
6. The method according to claim 5, characterized in that, The result of the reaction solution color change observed by the naked eye is as follows: if the color changes from light purple to light blue, it is judged as positive; if the color remains light purple, it is judged as negative. The color difference value determined by the colorimeter is as follows: The degree of color change of HNB from light purple to light blue is quantitatively evaluated by calculating the total color difference value ΔE between the reaction endpoint and the reaction start point, as well as the shift in the ratio of a* / b*. When ΔE ≥ 5 and the chromaticity coordinate shift ratio a* / b* ≥ -0.10, it is judged as positive; when ΔE ≤ 3.00 and a* / b* ≤ -0.30, it is judged as negative.
7. The method according to claim 5, characterized in that, The isothermal amplification micro-reaction solution contains free Mg 2+ The final concentration was 8 mmol / L.
8. The use of the primer set according to claim 1 or the kit according to any one of claims 2 to 4 in the preparation of products for detecting resistance genes of macrolides and / or amide alcohols.
9. The application according to claim 8, characterized in that, The targeted macrolide antibiotic resistance genes include ermA Genes and ermB Genes; the amide alcohol antibiotic resistance genes include catA Genes and floR Gene.
